US Physical Therapy Q1 2024 Adj EPS $0.51 Misses $0.56 Estimate, Sales $155.675M Beat $153.366M Estimate
Portfolio Pulse from Benzinga Newsdesk
US Physical Therapy (USPH) reported Q1 2024 adjusted EPS of $0.51, missing the $0.56 estimate, and sales of $155.675M, beating the $153.366M estimate. This represents a 13.56% decrease in EPS and a 4.83% increase in sales year-over-year.
May 07, 2024 | 10:07 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
US Physical Therapy reported a Q1 2024 adjusted EPS of $0.51, missing estimates, with sales of $155.675M, exceeding expectations.
The miss in EPS estimates may negatively impact investor sentiment, but the beat on sales forecasts could offset this. The mixed results present a neutral short-term outlook for USPH's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100